Prolonged first-line PEG-asparaginase treatment in pediatric acute lymphoblastic leukemia in the NOPHO ALL2008 protocol-Pharmacokinetics and antibody formation-Reference-Cited by-同舟云学术

Prolonged first-line PEG-asparaginase treatment in pediatric acute lymphoblastic leukemia in the NOPHO ALL2008 protocol-Pharmacokinetics and antibody formation

Published:2017-06-29 Issue:12 Volume:64 Page:e26686
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Tram Henriksen Louise¹,Gottschalk Højfeldt Sofie¹^ORCID,Schmiegelow Kjeld²³,Frandsen Thomas Leth²,Skov Wehner Peder⁴,Schrøder Henrik¹,Klug Albertsen Birgitte¹,

Affiliation:

1. Department of Pediatrics; Aarhus University Hospital; Aarhus Denmark

2. Department of Pediatric and Adolescent Medicine; Copenhagen University Hospital; Copenhagen Denmark

3. Faculty of Medicine; Institute of Clinical Medicine; University of Copenhagen; Copenhagen Denmark

4. Department of Pediatrics; Hans Christian Andersen Children's Hospital; Odense University Hospital; Odense Denmark

Funder

Børnecancerfonden

Kraeftens Bekaempelse

M.L. Jørgensen and Gunnar Hansen Foundation

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference43 articles.

1. Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000);Silverman;Leukemia,2010

2. Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia;Moghrabi;Blood,2007

3. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia;Schmiegelow;Leukemia,2010

4. Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000;Schrappe;Klin Padiatr,2013

5. Treatment of acute lymphoblastic leukemia;Pui;N Engl J Med,2006

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitigating the Effects of Persistent Antipolymer Immune Reactions in Nanomedicine: Evaluating Materials-Based Approaches Using Molecular Imaging;ACS Nano;2024-07-22

2. Anti-PEG antibodies: Current situation and countermeasures;Nano Today;2024-04

3. Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia;Leukemia;2024-01-29

4. Increase in PEG-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia;2023-11-30

5. A Review of L-Asparaginase Hypersensitivity in Paediatric Acute Lymphoblastic Leukaemia Patients with Regard to the Measurement of Anti-Asparaginase Antibodies and Their Genetic Predisposition;Malaysian Journal of Medical Sciences;2023-10-30